Status:
COMPLETED
Evaluation of Varenicline Safety, Tolerability, Pharmacokinetics and Pro-Cognitive Effects in Healthy Elderly Non-Smoking Subjects
Lead Sponsor:
Pfizer
Conditions:
Healthy
Non-Smoking
Eligibility:
All Genders
65-85 years
Phase:
PHASE1
Brief Summary
1. Characterize the tolerability and safety of repeated doses of varenicline in healthy non-smoking elderly subjects. 2. Describe the steady state pharmacokinetics of varenicline in healthy non-smokin...
Eligibility Criteria
Inclusion
- Healthy, Elderly (65-85 years inclusive), Non-smoker
Exclusion
- Creatinine Clearnace \< 30 ml/min, Evidence or history of clinically significant, unstable diseases
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00694044
Start Date
April 1 2008
End Date
June 1 2008
Last Update
June 2 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Miami, Florida, United States, 33169
2
Pfizer Investigational Site
Orlando, Florida, United States, 32809